| | | | | |
AARD Aardvark Therapeutics, Inc. Common Stock | $5,8700 | -0,85% | $126,71M | $33,49K | |
FXAC FortuneX Acquisition Corporation Ordinary shares | $10,0800 | +0,29% | $126,57M | $9,33K | |
INVZ Innoviz Technologies Ltd. Ordinary shares | $0,33400 | -0,45% | $126,53M | $1,29M | |
SJT San Juan Basin Royalty Trust UBI | $2,8860 | +1,26% | $126,30M | $40,58K | |
SANG Sangoma Technologies Corporation Common Shares | $3,8400 | -1,54% | $126,12M | $13,09K | |
CBUS Cibus, Inc. Class A Common Stock | $1,5350 | -1,60% | $126,10M | $60,11K | |
RDZN Roadzen, Inc. Ordinary Shares | $1,2550 | -9,71% | $126,04M | $417,00K | |
NYXH Nyxoah SA Ordinary Shares | $1,5050 | +1,01% | $126,03M | $63,85K | |
MXCT MaxCyte, Inc. Common Stock | $1,2550 | +1,21% | $125,91M | $357,53K | |
| $19,4750 | -1,04% | $125,78M | $2,33K | |
GGZ The Gabelli Global Small and Mid Cap Value Trust | $16,2800 | +0,56% | $125,64M | $3,81K | |
NMI Nuveen Municipal Income | $10,3950 | -0,53% | $125,61M | $31,15K | |
| $1,1650 | -2,10% | $125,56M | $108,42K | |
BMEA Biomea Fusion, Inc. Common Stock | $1,8750 | +4,17% | $125,39M | $1,40M | |
LIXT Lixte Biotechnology Holdings, Inc. Common Stock | $7,2850 | +1,04% | $125,35M | $610,69K | |
